DISOPYRAMIDE PHOSPHATE

Post-LOE

disopyramide phosphate

Dr. Reddy's Laboratories

ANDAORALCAPSULE

Approved

May 1985

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

4/8 — Partial

DISOPYRAMIDE PHOSPHATE (disopyramide phosphate) by Dr. Reddy's Laboratories is mechanisms of action disopyramide phosphate is a type 1 antiarrhythmic drug (i. Approved for documented ventricular arrhythmias, such, that and 2 more indications. First approved in 1985.

Drug data last refreshed 18h ago

$0.0BPart D

Mechanism of Action

Mechanisms of Action Disopyramide phosphate is a Type 1 antiarrhythmic drug (i.e., similar to procainamide and quinidine). In animal studies disopyramide decreases the rate of diastolic depolarization (phase 4) in cells with augmented automaticity, decreases the upstroke velocity (phase 0) and…

Indications (5)

documented ventricular arrhythmias such

Worked on DISOPYRAMIDE PHOSPHATE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.